After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

(MedPage Today) — WASHINGTON — Liver cancer risk after hepatitis C virus (HCV) cure was significantly greater in patients with metabolic dysfunction-associated steatotic liver disease (MASLD), according to a retrospective cohort study from…

Source link : https://www.medpagetoday.com/meetingcoverage/aasld/118517

Author :

Publish date : 2025-11-13 22:42:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
					1	2
3	4	5	6	7	8	9
10	11	12	13	14	15	16
17	18	19	20	21	22	23
24	25	26	27	28	29	30

After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

Evidence Linking Processed Foods and Early Colon Cancer Grows

Related Posts

Evidence Linking Processed Foods and Early Colon Cancer Grows

Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar

GOP Promised Healthcare Negotiations After the Shutdown, but Dems Are Wary

Medicare’s Big Opportunity: Paying for Prevention

Falls Drop Sharply With Lactulose, Tai Chi Combo in Cirrhosis Trial

RFK Jr. ‘Diss Track’; Med Student Qualifies for Olympic Trials; Infant Formula PSA

After Hepatitis C Cure, MASLD May Boost Liver Cancer Risk

Evidence Linking Processed Foods and Early Colon Cancer Grows

Key HER2-Positive Breast Cancer Therapy Gets Its First Biosimilar

GOP Promised Healthcare Negotiations After the Shutdown, but Dems Are Wary

Medicare’s Big Opportunity: Paying for Prevention

Falls Drop Sharply With Lactulose, Tai Chi Combo in Cirrhosis Trial

RFK Jr. ‘Diss Track’; Med Student Qualifies for Olympic Trials; Infant Formula PSA

Two Drugs Approved for NPM1-Mutated Leukemia

Categories

Archives